
PF-05190457
CAS No. 1334782-79-4
PF-05190457( PF05190457 | PF 5190457 | PF5190457 )
Catalog No. M11337 CAS No. 1334782-79-4
A potent, selective, and orally bioavailable ghrelin receptor (GHSR) inverse agonist with binding pKi of 8.36; displays excellent off-target activity in the CEREP panel at 10 uM with exception of serotonin 5-HT2B (IC50=3.7 uM).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 40 | In Stock |
![]() ![]() |
5MG | 65 | In Stock |
![]() ![]() |
10MG | 115 | In Stock |
![]() ![]() |
25MG | 260 | In Stock |
![]() ![]() |
100MG | Get Quote | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NamePF-05190457
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective, and orally bioavailable ghrelin receptor (GHSR) inverse agonist with binding pKi of 8.36; displays excellent off-target activity in the CEREP panel at 10 uM with exception of serotonin 5-HT2B (IC50=3.7 uM).
-
DescriptionA potent, selective, and orally bioavailable ghrelin receptor (GHSR) inverse agonist with binding pKi of 8.36; displays excellent off-target activity in the CEREP panel at 10 uM with exception of serotonin 5-HT2B (IC50=3.7 uM); demonstrates robust increases in glucose-stimulated insulin secretion in human islets.Alcoholism Phase 2 Clinical.
-
In VitroPF-5190457 has a superior balance of ghrelin receptor pharmacology and off-target selectivity.
-
In VivoPF-5190457 has excellent selectivity and demonstrates robust increases in glucose-stimulated insulin secretion in human whole and dispersed islets.
-
SynonymsPF05190457 | PF 5190457 | PF5190457
-
PathwayGPCR/G Protein
-
TargetGHSR
-
RecptorGHSR
-
Research AreaNeurological Disease
-
IndicationAlcoholism
Chemical Information
-
CAS Number1334782-79-4
-
Formula Weight512.676
-
Molecular FormulaC29H32N6OS
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (487.64 mM)
-
SMILESCC1=CC(C2=CC3=C([C@H](N4CC5(CCN(C(CC(N=C6S7)=CN6C=C7C)=O)CC5)C4)CC3)C=C2)=NC=N1
-
Chemical Name(R)-2-(2-methylimidazo[2,1-b]thiazol-6-yl)-1-(2-(5-(6-methylpyrimidin-4-yl)-2,3-dihydro-1H-inden-1-yl)-2,7-diazaspiro[3.5]nonan-7-yl)ethan-1-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Bhattacharya SK, et al. ACS Med Chem Lett. 2014 Feb 24;5(5):474-9.
2. Kong J, et al. Br J Pharmacol. 2016 May;173(9):1452-64.
3. Denney WS, et al. Br J Clin Pharmacol. 2017 Feb;83(2):326-338.
molnova catalog



related products
-
ONC212
ONC212 a fluorinated-ONC201 analogue is a selective agonist of GPR132.
-
Human growth hormone...
Human growth hormone-releasing factor stimulates GH production and release by binding to the GHRH Receptor (GHRHR) on cells in the anterior pituitary.Growth hormone-releasing hormone is a hormone produced in the hypothalamus. The main role of growth hormone-releasing hormone is to stimulate the pituitary gland to produce and release growth hormone into the bloodstream.
-
JMV 2959
JMV 2959 is a growth hormone secretagogue receptor type 1a (GHS-R1a) antagonist with an IC50 of 32 nM.